- Injective’s on-chain statistics showed that the recent outbreak beyond $ 14.4 offered good buying.
- The question of token has been delayed in the past two weeks, but this was just a small reason for concern.
Injective [INJ] Was risen by 8.2% in 24 hours and the daily trade volume increased by almost 40%, which was a bullish sign.
The Golf Stoot came when the prize challenged the $ 14 resistance zone and the movement beyond this level was supported by a big question.

Source: Inj/USDT on TradingView
The One -day price diagram illustrates the bullish bias of Inj in recent weeks. It was a range under $ 11 in March and April.
That rally was not random – it came with rising volume and was supported by a clear structure.
The A/D indicator confirmed the increased demand with its higher highlights and higher lows since April. This upward trend has been delayed in the last two weeks.
The balance between bulls and bears was now neutral.
Nevertheless, injectively managed to break through the local resistance of $ 14.42, a level marked by the 78.6% Fibonacci retracement at $ 14.16.
The MacD flashed a bullish crossover, which suggests that the momentum was back in favor of buyers.
That is why the step was $ 14.2- $ 14.4 a solid sign of Bullish Intention. Increased purchase volume would maintain the rally and possibly push as high as $ 18.6 or $ 22.4.
Injective traders may not want to wait for elevated goals.
A dense cluster appeared around $ 15- $ 15.5 on Bybit’s Liquidation Harmap and Inj was able to raise. After that, token may need time for consolidation before the next impulse movement is higher.
This is the movement that indicates that investors indicated that investors could buy.
Inj Metrics Flash Buy Signal – Is it too late?
The data from Santiment showed that the development activity was fairly stable in 2025, despite the volatile prize trends. This was a good sign for long -term investors.
Another positive sign was the uptrend in the average currency since the end of January.
The reflected network -wide accumulation, because the token traded within a range for two months. The recent outbreak saw some winning at the end of April, but the metric rose again.
Moreover, the 180-day MVRV remained a negative field.
That meant holders during this period were on average still losses, and that in turn meant that the price was not a high risk due to profitable activity.
Together, the network statistics and the price diagram indicated that injectively offered a buying. The steady daily active addresses and development activities at the chain were also encouraging factors.